5.6% dividend yield forecast! 1 UK share I’d buy in October and hold for 10+ years

This little-known biotech group has hiked its dividend yield for 10 years in a row, and forecasts suggest this trend will continue through 2026!

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investor appetites for big dividend yields continue to grow thanks to inflation-driven demand for extra passive income. However, while there are countless high-yielding opportunities across the London Stock Exchange right now, most look unsustainable in the long run.

Since I don’t want to keep juggling between different income stocks over the next decade and beyond, I’m hunting for a certain type of dividend stock. Specifically, I’m looking for one that doesn’t just maintain payouts but grows them each year as well. And that’s put Bioventix (LSE:BVXP) in my sights.

Sustainable passive income

For a company to supply continuously rising dividends, it needs two key traits. The first is to have a cash-generative business model. The other is to provide a product or service that will remain in demand for decades. Bioventix seems to have both of these characteristics.

Should you invest £1,000 in Bioventix Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Bioventix Plc made the list?

See the 6 stocks

It’s a biotech firm that specialises in manufacturing sheep monoclonal antibodies. In oversimplified terms, these are used in diagnostic medicine to detect heart disease, cancer, infertility, and potentially even Alzheimer’s if the latest ongoing tests prove successful.

Needless to say, detecting diseases isn’t likely to go out of fashion any time soon. And while there are other antibody suppliers around the world, Bioventix’s product portfolio has built a reputation for quality.

It’s undoubtedly a niche product. Yet demand continues to grow, enabling it to consistently boost revenue, earnings and free cash flow generation. So much so that the firm is entirely debt-free and has been consistently hiking its dividend for 10 years in a row.

Right now, the shares are offering a slightly better-than-average dividend yield of 4.1%. But based on analysts’ forecasts, this level of payout is set to continue growing to as high as 5.6% by 2026. And if the trends continue, it may rise even further thereafter.

Everything has its risks

Looking at the numbers, Bioventix’s track record is pretty admirable. And this has also been reflected in its stock price. Since going public in April 2014, the shares of the biotech group have climbed more than 600%!

Created with Highcharts 11.4.3Bioventix Plc PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

However, even the best-looking businesses in the world have their weak spots. The difficulty of manufacturing monoclonal antibodies has proven to be quite a powerful barrier to entry against would-be competitors. Yet it’s also proven to be a handicap in terms of increasing production capacity.

At the same time, while diagnostic medicine is in constant demand, the types of antibodies required can be somewhat cyclical. The group’s Troponin antibodies have seen softer-than-expected sales, according to the group’s most recent interim report.

Furthermore, government changes to the headline corporation tax rate are also expected to adversely impact earnings as well as cash flows. This change is obviously out of management’s control. Nevertheless, it adds pressure to the group’s profitability and, in turn, dividends.

Despite these headwinds, I remain cautiously optimistic for this business. Its valuation comes with a small premium that invites some extra volatility. Yet given the long-term relevance of its products and the group’s impressive track record, it’s a premium I’m happy to pay. That’s why I’m planning on adding this business to my income portfolio once I have cash available.

5 Shares for the Future of Energy

Investors who don’t own energy shares need to see this now.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.

While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.

Open this new report5 Shares for the Future of Energy — and discover:

  • Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
  • How to potentially get paid by the weather
  • Electric Vehicles’ secret backdoor opportunity
  • One dead simple stock for the new nuclear boom

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has recommended Bioventix Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man smiling and working on laptop
Investing Articles

3 FTSE 250 shares with low P/E ratios and sky-high dividend yields!

Searching for the best bargains that London has to offer? Here's a handful from the FTSE 250 I think are…

Read more »

Investing Articles

Why is Apple stock lagging the S&P 500 in 2025?

Our writer is wondering whether now might be an opportune time to snap up shares of the largest company in…

Read more »

Investing Articles

Here’s how an ISA investor could build a £20k passive income with UK shares

Looking to make a five-figure passive income in retirement? Here's how a blend of UK shares and cash savings could…

Read more »

Investing Articles

£10,000 in savings? Here’s how an investor can target £3,560 in annual passive income

Paul Summers explains how an investor could target making thousands of pounds in passive income by holding great dividend stocks…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Up 490%, Lion Finance Group is a new name on the FTSE 250… but what is it?

Many investors won’t be familiar with Lion Finance Group, but the FTSE 250 stock has surged 490% over five years.…

Read more »

Growth Shares

I think this is the most punished FTSE stock in the market right now

Jon Smith talks through a FTSE company that has endured problems but is one he believes has a brighter future…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

Stock market correction! 1 growth share down 53% to consider buying now

This writer highlights a growth stock that has hit a rough patch in recent weeks. Here's why it might be…

Read more »

Investing Articles

Here’s why the Tesco share price has dropped 18% in a month!

Tesco's share price has lost nearly a fifth of its value since mid-February. Is this FTSE 100 dividend stock now…

Read more »